DIAMEDICA THERAPEUTICS INC. (DMAC) Shareholders’ equity
DIAMEDICA THERAPEUTICS INC. (DMAC) shareholders’ equity at each fiscal year-end, per SEC filings.
$17.0MFY2019
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice